R Muniyappa, RJ Karne, G Hall, SK Crandon, JA … - Diabetes, 2006 - Am Diabetes Assoc Glucosamine is a popular nutritional supplement used to treat osteoarthritis. Intravenous administration
of glucosamine causes insulin resistance and endothelial dysfunction. However, rigorous clinical
studies evaluating the safety of oral glucosamine with respect to metabolic and ... Cited by 18 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org SG Albert, F Oiknine… - Diabetes Care, 2007 - Am Diabetes Assoc OBJECTIVE—Dietary and nutritional supplements are modulators of HDL cholesterol levels
and production of apolipoprotein (apo) AI. Previously, in vitro treatment of hepatocyte cell lines
with glucosamine increased apoAI production by stabilization of apoAI mRNA. The ... Cited by 2 - Related articles - BL Direct - All 5 versions
T Pham, A Cornea, KE Blick, A Jenkins, RH … - The American journal of …, 2007 - journals.lww.com ABSTRACT: Background:Glucosamine is used to treat osteoarthritis. In animals, the compound
is known to cause insulin resistance, the underlying abnormality in type 2 diabetes mellitus. Insulin
resistance in humans taking oral glucosamine in doses used for osteoarthritis has not ... Cited by 9 - Related articles - BL Direct - All 4 versions
PD Marshall, S Poddar, EM Tweed, L … - The Journal of family …, 2006 - ncbi.nlm.nih.gov Despite theoretical risks based on animal models given high intravenous doses,
glucosamine/chondroitin (1500 mg/1200 mg daily) does not adversely affect short-term glycemic
control for patients whose diabetes is well-controlled, or for those without diabetes or ... Cited by 4 - Related articles - BL Direct - All 4 versions
J Villacis, TR Rice, LR Bucci, JM El-Dahr, … - Clinical and …, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 8 - Related articles - BL Direct - All 5 versions
BA Biggee, CM Blinn, M Nuite, JE Silbert, TE … - British Medical …, 2006 - ard.bmj.com Online First articles must include the digital object identifier (DOIs) and date of initial
publication. establish publication priority; they are indexed by PubMed from initial
publication. Citations to may be posted when available prior to final publication). Online ... Cited by 12 - Related articles - BL Direct - All 4 versions
MG Wallis, ME Smith, CM Kolka, L Zhang, SM Richards … - Diabetologia, 2005 - Springer Abstract Aims/hypothesis: Glucose toxicity and glucos- amine-induced insulin resistance have
been attributed to products of glucosamine metabolism. In addition, endothelial cell nitric oxide
synthase is inhibited by glucosamine. Since insulin has endothelial ... Cited by 12 - Related articles - BL Direct - All 4 versions
K Mehta, J Gala, S Bhasale, S Naik, M … - BMC complementary …, 2007 - biomedcentral.com Subjects (n = 95) were screened and randomized to receive glucosamine sulfate (n = 47, 1500
mg/day) or reparagen (n = 48, 1800 mg/day), a polyherbal consisting of 300 mg of vincaria (Uncaria
guianensis) and 1500 mg of RNI 249 (Lepidium meyenii) administered orally, twice daily. ... Cited by 2 - Related articles - Cached - All 10 versions
AH Mulder, APJ van Dijk, P Smits, CJ Tack - Microcirculation, 2008 - informahealthcare.com Results: After an intravenous bolus injection of the contrast agent, the steady-state concentration
of contrast agent in forearm muscle lasted long enough (approximately 190 seconds) for the
duration of the measurements (which take 70–80 seconds), rendering the continuous ... Cited by 2 - Related articles - BL Direct - All 5 versions
